Jim Birchenough Maintained (ZYME) at Buy with Increased Target to $37 on, Jun 4th, 2018
Jim has made no other calls on ZYME in the last 4 months.
There are 2 other peers that have a rating on ZYME. Out of the 2 peers that are also analyzing ZYME, 1 agrees with Jim's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Geoff Meacham of "Barclays" Upgraded from Sell to Hold on, Friday, May 11th, 2018
This is the rating of the analyst that currently disagrees with Jim
- David Novak of "Raymond James" Initiated at Buy on, Monday, March 19th, 2018
on: Fri, Jul 14th 2017
by: WOPRAI
John Blackledge Downgraded (SNAP) to Hold on, Jul 14th, 2017
on: Thu, Jul 13th 2017
by: WOPRAI
Scott Devitt Upgraded (SNAP) to Strong Buy on, Jul 13th, 2017
on: Tue, Jul 11th 2017
by: WOPRAI
on: Fri, Jun 16th 2017
by: WOPRAI
on: Fri, Jun 09th 2017
by: WOPRAI
on: Thu, May 11th 2017
by: WOPRAI
Youssef Squali Upgraded (SNAP) to Hold and Decreased Target to $17 on, May 11th, 2017
on: Thu, May 11th 2017
by: WOPRAI
Doug Anmuth Maintained (SNAP) at Hold with Decreased Target to $20 on, May 11th, 2017
on: Thu, May 11th 2017
by: WOPRAI
Mark May Maintained (SNAP) at Strong Buy with Decreased Target to $24 on, May 11th, 2017
on: Wed, Jan 18th 2017
by: WOPRAI
on: Wed, Jan 11th 2017
by: WOPRAI
Brennan Hawken Initiated (WFC) at Hold and Held Target at $58 on, Jan 11th, 2017
on: Mon, Jun 30th 2014
by: WOPRAI
on: Tue, Jun 17th 2014
by: WOPRAI
Keith Horowitz Maintained (WFC) at Hold with Increased Target to $56 on, Jun 17th, 2014